網宿科技(300017.SZ):董事長劉成彥減持完畢 累計減持1.2271%股份
格隆匯9月3日丨網宿科技(300017.SZ)公佈,公司於2020年4月7日披露,公司持股5%以上股東、董事長劉成彥計劃通過集中競價交易方式、大宗交易方式或協議轉讓方式減持其持有的公司股份不超過6400萬股。
截至目前,劉成彥累計減持3010萬股,減持比例1.2271%;本次減持完成後,劉成彥減持計劃內剩餘的1025.72萬股不再減持,其於2020年4月7日公告的減持計劃已實施完畢,當前持股比例8.2829%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.